UAB "West-pharma-East" Finance - revenue, profit
Financial ratios
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 1,337,703 |
| 262,810 |
| 125,988 |
| 105,165 |
| 20,661 |
| 58.52 |
| 7.86 |
| 500,401 |
| 441,373 |
| 58,849 |
| 877,006 |
| 2024 |
|---|
| 1,339,173 |
| 267,835 |
| 172,751 |
| 140,383 |
| 28,077 |
| 71.65 |
| 10.48 |
| 553,005 |
| 231,206 |
| 33,846 |
| 744,121 |
| 2025 |
|---|
| 1,258,909 |
| 299,740 |
| 109,219 |
| 90,659 |
| 21,585 |
| 73.55 |
| 7.20 |
| 562,253 |
| 154,025 |
| 6,685 |
| 703,923 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 1,258,909 |
| 299,740 |
| 109,219 |
| 90,659 |
| 21,585 |
| 73.55 |
| 7.20 |
| 562,253 |
| 154,025 |
| 6,685 |
| 703,923 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
1,258,909 €-6 % *
Sales per employee (€)
299,740 €12 % *
Profit before tax (€)
109,219 €-37 % *
Net Profit (€)
90,659 €-35 % *
Profit per employee (€)
21,585 €-23 % *
Total profitability (%)
73.55 %2.65 % *
Net profitability (%)
7.20 %-31.30 % *
Equity (€)
562,253 €2 % *
Amounts Payable And Liabilities (€)
154,025 €-33 % *
Non-current Assets (€)
6,685 €-80 % *
CurrentAssets (€)
703,923 €-5 % *
